UB Paderborn / Katalog / Suche / in CDI

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

Journal of clinical lipidology, 2008-10, Vol.2 (5), p.375-383

2008

Link zum Volltext

Verfügbarkeit prüfen

42268 Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Psoriasis in Europe

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB216-AB216

2023

Link zum Volltext

Verfügbarkeit prüfen

REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S109-S110

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate

Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.831

2017

Link zum Volltext

Verfügbarkeit prüfen

REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S109-S110

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe

Advances in therapy, 2024, Vol.41 (1), p.331-348

2024

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms

Cancer letters, 2000-09, Vol.157 (2), p.133-144

2000

Link zum Volltext

Verfügbarkeit prüfen

Challenges and Opportunities in IBD Clinical Trial Design

Gastroenterology, 2021-08, Vol.161 (2), p.400-404

2021

Link zum Volltext

Verfügbarkeit prüfen

Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies

Journal of rheumatology, 2016-09, Vol.43 (9), p.1637

2016

Link zum Volltext

Verfügbarkeit prüfen

A meningioma-mimicking tumor caused by Mycobacterium avium complex in an immunocompromised patient

The American journal of surgical pathology, 2000, Vol.24 (1), p.136-139

2000

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a LC/MS/MS method for 6-keto PGF sub(1 alpha , a metabolite of prostacyclin (PGI) sub(2))

Journal of pharmaceutical and biomedical analysis, 2011-11, Vol.56 (3), p.600-603

2011

Link zum Volltext

Verfügbarkeit prüfen

Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction

European journal of heart failure, 2013-06, Vol.15 (6), p.679-689

2013

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI2)

Journal of pharmaceutical and biomedical analysis, 2011-11, Vol.56 (3), p.600-603

2011

Link zum Volltext

Verfügbarkeit prüfen

The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin

Platelets (Edinburgh), 2014-11, Vol.25 (7), p.480-487

2014

Link zum Volltext

Verfügbarkeit prüfen

A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel

Platelets (Edinburgh), 2012-06, Vol.23 (4), p.249-258

2012

Link zum Volltext

Verfügbarkeit prüfen

The effects of laropiprant, a selective prostaglandin D 2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Platelets (Edinburgh), 2011-11, Vol.22 (7), p.495-503

2011

Link zum Volltext

Verfügbarkeit prüfen

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Platelets (Edinburgh), 2011-11, Vol.22 (7), p.495-503

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

Platelets (Edinburgh), 2010, Vol.21 (3), p.191-198

2010

Link zum Volltext

Verfügbarkeit prüfen

The effects of multiple doses of rolofylline on the single-dose pharmacokinetics of midazolam in healthy subjects

American journal of therapeutics, 2010-01, Vol.17 (1), p.53

2010

Link zum Volltext

Verfügbarkeit prüfen

A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers

American journal of therapeutics, 2010-01, Vol.17 (1), p.8

2010

Link zum Volltext

Verfügbarkeit prüfen

Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria

Journal of cutaneous pathology, 2004-04, Vol.31 (4), p.323-329

2004

Link zum Volltext

Verfügbarkeit prüfen

The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO‐donors

British journal of pharmacology, 1990-12, Vol.101 (4), p.991-995

1990

Link zum Volltext

Verfügbarkeit prüfen

Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs

Archives of dermatology (1960), 2003-12, Vol.139 (12), p.1577

2003

Link zum Volltext

Verfügbarkeit prüfen

Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation

European journal of pharmacology, 1991-06, Vol.199 (1), p.15-18

1991

Link zum Volltext

Verfügbarkeit prüfen

N G-hydroxy- l-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta

Biochemical and biophysical research communications, 1992, Vol.189 (2), p.711-716

1992

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

42268 Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Psoriasis in Europe

REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE

A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate

REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE

Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe

Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms

Challenges and Opportunities in IBD Clinical Trial Design

Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies

A meningioma-mimicking tumor caused by Mycobacterium avium complex in an immunocompromised patient

Development and validation of a LC/MS/MS method for 6-keto PGF sub(1 alpha , a metabolite of prostacyclin (PGI) sub(2))

Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction

Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI2)

The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin

A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel

The effects of laropiprant, a selective prostaglandin D 2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

The effects of multiple doses of rolofylline on the single-dose pharmacokinetics of midazolam in healthy subjects

A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers

Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria

The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO‐donors

Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs

Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation

N G-hydroxy- l-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta

Suchergebnisse filtern